Terbinafine Tablet
Product Images NDC 62135-572

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbinafine (NDC 62135-572). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Terbinafine Tablets, Usp 250 mg (NDC 62135-572-30)

Terbinafine Tablets USP 250 mg oral tablets label by Chartwell Rx, LLC. The label indicates a package of 30 tablets with Rx only status. It includes dosage information and storage instructions, featuring the NDC code 62135-572.*

FDA Label Image

Terbinafine Tablets, Usp 250 mg (NDC 62135-572-90)

Label for Terbinafine Tablets, USP 250 mg, oral tablet prescription medication by Chartwell Rx, containing 90 tablets. The label includes dosage information, storage instructions, and barcode. Manufactured by Chartwell RX, LLC, Congers, NY, USA.*

FDA Label Image

Terbinafine Structure (Terbinafine Tablets Usp Structure)

Chemical structure of terbinafine hydrochloride, the active ingredient in TERBINAFINE 250 mg oral tablets. The diagram shows its molecular composition including aromatic rings and alkyl side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.